门窦血管性肝病伴门静脉高压与肝硬化:CT及肝胆对比剂增强MRI影像特征差异
回顾性病例对照研究将43例门窦血管性肝病(PSVD)患者按1:3匹配129例肝硬化患者,比较CT与肝胆期MRI特征。PSVD组肝表面结节更少(16.3% vs 89.2%)、尾状叶/右叶比值增大及门静脉异常更多、肝胆期实质强化更亮;PSVD组72.1%初诊被误诊为肝硬化,诊断延迟更长(32个月 vs 4个月),14%有FNH样结节。
要点
- PSVD肝表面结节少见(16.3% vs 肝硬化89.2%),是鉴别肝硬化的关键阴性征象。
- 尾状叶/右叶比值增大、实质强化不均及门静脉异常更提示PSVD。
- PSVD肝胆期实质强化较肝硬化更亮,且门静脉高压分级更高。
核心结论
- CT及肝胆对比剂增强MRI的部分影像特征可鉴别PSVD与肝硬化;PSVD可发生良性局灶性病变,最常见为FNH样结节。
研究设计与样本
- 回顾性病例对照研究,纳入43例PSVD患者与129例肝硬化患者,按肝功能以1:3比例匹配;分析初诊诊断与最终诊断时间,采用广义线性混合模型比较CT及肝胆对比剂增强MRI肝胆期实质强化特征。
关键影像表现/征象
- PSVD组肝表面结节出现率低于肝硬化组(16.3% vs 89.2%,p < 0.001)。
- PSVD组尾状叶/右叶比值增大、实质强化不均及门静脉异常较肝硬化组更常见(均p < 0.001)。
- PSVD组门静脉高压分级显著高于肝硬化组(p < 0.001)。
- PSVD组肝胆期实质强化较肝硬化组更亮(p < 0.001)。
- PSVD组14%患者至少有一个局灶性肝脏病变,主要为FNH样结节。
诊断标准与关键数值
- 肝表面结节在PSVD组出现率16.3%、肝硬化组89.2%(p < 0.001)。
- PSVD组尾状叶/右叶比值增大、实质强化不均、门静脉异常均较肝硬化组更常见(均p < 0.001)。
- PSVD组门静脉高压分级显著高于肝硬化组(p < 0.001);肝胆期实质强化PSVD组较肝硬化组更亮(p < 0.001)。
临床应用与阅片要点
- 阅片时肝表面结节稀少而门静脉高压征象明显者,应考虑PSVD而非典型肝硬化。
- 注意评估尾状叶/右叶比值、实质强化均匀性及门静脉异常,这些征象更支持PSVD。
- 肝胆期MRI上PSVD实质强化较肝硬化更亮,可作辅助鉴别点。
- PSVD患者可伴FNH样结节等良性局灶性病变,报告时避免误判为恶性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To differentiate the computed tomography (CT) and magnetic resonance imaging (MRI) features of porto-sinusoidal vascular disease (PSVD) and liver cirrhosis (LC).
METHODS: In this retrospective case-control study of patients with PSVD matched in a 1:3 ratio with LC patients according to liver function, initial diagnosis and time to final diagnosis were analyzed. Imaging features on CT and the parenchymal enhancement on hepatobiliary phase of hepatobiliary agent-enhanced MRI (HBA-MRI) were compared using a generalized linear mixed model. Focal hepatic lesions in the PSVD group were analyzed.
RESULTS: In total, 43 PSVD patients and 129 LC patients were included. Among PSVD patients, 72.1% were initially misdiagnosed with LC. PSVD patients had a longer diagnostic delay than LC patients (32 months vs. 4 months; p < 0.001). Liver surface nodularity was less common in the PSVD group than in the LC group (16.3% vs. 89.2%, p < 0.001). Increased caudate-to-right lobe ratio, heterogeneous parenchymal enhancement, and portal vein abnormalities were more frequently noted in the PSVD group than in the LC group (all p < 0.001). The grade of portal hypertension was significantly higher in the PSVD group than in the LC group (p < 0.001), and they also had brighter parenchymal enhancement during the hepatobiliary phase of HBA-MRI (p < 0.001). In the PSVD group, 14% patients had at least one focal hepatic lesion, primarily a focal nodular hyperplasia (FNH)-like nodule.
CONCLUSIONS: Some imaging features on CT and HBA-MRI can distinguish PSVD from LC. Benign focal lesions, most commonly FNH-like nodules, can develop in PSVD.
引用
- Kang JH, Kim DH, Kim SY, et al. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI. Abdom Radiol (NY). 2020. PMID: 33095310. doi:10.1007/s00261-020-02831-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。